Detalhe da pesquisa
1.
Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy.
Hepatology
; 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38447019
2.
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).
Hepatology
; 79(1): 135-148, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37505221
3.
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease.
Gut
; 73(5): 825-834, 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38199805
4.
Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis.
Clin Gastroenterol Hepatol
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782175
5.
Predicting liver-related events in NAFLD: A predictive model.
Hepatology
; 78(4): 1240-1251, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36994693
6.
Novel insights into metabolic-associated steatotic liver disease preclinical models.
Liver Int
; 44(3): 644-662, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291855
7.
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry.
Liver Int
; 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38809086
8.
Circular RNAs in non-alcoholic fatty liver disease: Functions and clinical significance.
RNA Biol
; 21(1): 1-15, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113132
9.
aProceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH).
Gastroenterol Hepatol
; : 502207, 2024 May 07.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38723772
10.
Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis.
J Hepatol
; 79(4): 967-976, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37277075
11.
An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography.
J Hepatol
; 79(3): 592-604, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37121437
12.
Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD.
Liver Int
; 43(9): 1909-1919, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37288714
13.
Clinical application of Magnetic resonance elastography in hepatocellular carcinoma: from diagnosis to prognosis.
Ann Hepatol
; 28(2): 100889, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36572210
14.
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
Gut
; 71(2): 382-390, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33541866
15.
Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis.
J Hepatol
; 77(6): 1554-1563, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35872326
16.
Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events.
J Hepatol
; 76(5): 1013-1020, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35063601
17.
Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function.
J Hepatol
; 76(1): 11-24, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34555423
18.
A 2-Step Strategy Combining FIB-4 With Transient Elastography and Ultrasound Predicted Liver Cancer After HCV Cure.
Am J Gastroenterol
; 117(1): 138-146, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34817975
19.
Long non-coding RNA H19 as a biomarker for hepatocellular carcinoma.
Liver Int
; 42(6): 1410-1422, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35243752
20.
Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology.
Liver Int
; 42(8): 1783-1792, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35643936